Create Your Own Business Intelligence Website
Input the stock code or the company name     Search  

<02179.HK> - JIANGSU RECBIO TECHNOLOGY CO., LTD.

 
 Basic Datum
Company name Lot P/E P/B EPS DPS
RECBIO-B 500 -8.33 3.779 -1.3045 0.0
Profile Information Data Financial Ratios Profit Loss Cash Flow Balance Earnings Dividend
 
 
 
 Company Rating
Date Broker Company name Rating Target
≫More
 
 Company performance - Published
Date Company name Turnover* Profit* % Dividend
≫More
 
 Comment
2022-03-21 瑞科亦有研發涉及新冠、帶狀皰疹、流感及手足口病的產品。不過大部分均處於臨床I期或II階段,未有確實能推出市場日期。
 
2022-03-21 江蘇瑞科生物主力於HPV候選疫苗研發,核心產品是一款用於預防子宮頸癌的重組HPV九價疫苗,已處於III期臨床試驗階段。除瑞科,亦有多家本土疫苗企業正佈局九價HPV疫苗,如康樂衛士、萬泰生物、博唯生物的九價HPV疫苗也處於III期臨床階段。
 
 
 Top Gain / Loss Show All Charts 
 
 Value
Name Updated Value Change Change %
HSI 05-02 09:30 17797.7  34.7  0.2%
RECBIO-B 05-03 15:08 9.2  9.2  ∞%
≫More
 
 

 

88iv | Home |  Login
Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer
Copyright (C) 2024
Suntek Computer Systems Limited.
All rights reserved